• LAST PRICE
    10.0600
  • TODAY'S CHANGE (%)
    Trending Down-0.3400 (-3.2692%)
  • Bid / Lots
    10.0700/ 2
  • Ask / Lots
    10.1000/ 4
  • Open / Previous Close
    10.5200 / 10.4000
  • Day Range
    Low 10.0600
    High 10.5900
  • 52 Week Range
    Low 6.0650
    High 17.0185
  • Volume
    195,087
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 10.4
TimeVolumePHAT
09:32 ET387610.4
09:39 ET86410.54
09:41 ET10010.46
09:43 ET221010.48
09:48 ET10010.36
09:50 ET151210.385
09:52 ET180510.375
09:54 ET250010.33
09:57 ET20010.394
09:59 ET50510.4
10:01 ET130010.39
10:06 ET445010.41
10:08 ET284910.48
10:10 ET10010.47
10:12 ET120010.45
10:15 ET40010.47
10:17 ET124510.5
10:19 ET10010.51
10:21 ET60010.51
10:24 ET273010.5
10:26 ET13210.47
10:30 ET112010.43
10:32 ET123010.451
10:33 ET10010.47
10:35 ET15010.44
10:37 ET20010.425
10:39 ET10010.41
10:44 ET515910.43
10:46 ET102010.49
10:48 ET140010.49
10:50 ET77810.44
10:51 ET125010.46
10:55 ET56110.49
10:57 ET22610.46
11:00 ET20010.46
11:02 ET857210.51
11:04 ET275010.48
11:06 ET42010.51
11:08 ET10010.54
11:09 ET136010.49
11:11 ET20010.5
11:15 ET30010.465
11:18 ET291410.46
11:20 ET20010.445
11:24 ET89010.485
11:26 ET40010.47
11:27 ET78510.47
11:29 ET10010.485
11:31 ET20010.485
11:36 ET10010.495
11:38 ET20010.515
11:40 ET61310.51
11:42 ET10010.47
11:44 ET20010.46
11:49 ET87510.445
11:51 ET20010.455
11:56 ET100210.53
12:00 ET55510.49
12:02 ET279210.43
12:05 ET23210.4
12:07 ET30010.4
12:09 ET10010.365
12:12 ET10010.35
12:14 ET30010.33
12:16 ET10010.32
12:18 ET65010.34
12:21 ET17210.32
12:23 ET125710.34
12:25 ET40010.33
12:27 ET109610.29
12:32 ET13910.275
12:34 ET40010.32
12:38 ET14710.33
12:39 ET103610.24
12:48 ET10110.26
12:50 ET58310.26
12:54 ET10010.24
12:56 ET186910.24
12:57 ET130010.22
12:59 ET39710.21
01:01 ET262510.202
01:03 ET126910.23
01:06 ET100010.2428
01:15 ET30010.29
01:19 ET20010.287
01:21 ET10010.287
01:26 ET80010.275
01:28 ET63710.2661
01:32 ET31610.23
01:33 ET10010.22
01:35 ET20210.19
01:37 ET20010.17
01:39 ET166010.195
01:42 ET20010.18
01:48 ET717410.19
01:50 ET50010.23
01:51 ET70010.21
01:53 ET50010.2
01:55 ET39610.205
01:57 ET10010.19
02:00 ET70010.2
02:02 ET10010.195
02:04 ET30010.195
02:06 ET10010.195
02:08 ET10010.2
02:09 ET30010.21
02:13 ET78810.24
02:15 ET20010.235
02:18 ET40010.22
02:24 ET80010.23
02:27 ET55010.24
02:31 ET10010.22
02:33 ET20010.21
02:38 ET20010.23
02:40 ET43410.22
02:47 ET10010.21
02:51 ET980110.181
02:54 ET20010.2
02:58 ET90010.18
03:00 ET20010.18
03:02 ET197410.185
03:03 ET770810.13
03:05 ET110010.14
03:07 ET70010.145
03:09 ET215710.158
03:12 ET783010.12
03:14 ET50010.11
03:16 ET98710.11
03:18 ET30010.11
03:21 ET251210.085
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPHAT
Phathom Pharmaceuticals Inc
598.2M
-2.3x
---
United StatesGHRS
GH Research PLC
596.2M
-17.0x
---
United StatesHUMA
Humacyte Inc
595.4M
-4.6x
---
United StatesLXRX
Lexicon Pharmaceuticals Inc
607.2M
-2.0x
---
United StatesPRME
Prime Medicine Inc
609.2M
-2.3x
---
United StatesREPL
Replimune Group Inc
584.3M
-2.7x
---
As of 2024-06-28

Company Information

Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s pipeline product candidate, VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan has also demonstrated clinical benefits in the treatment of erosive gastroesophageal reflux disease (erosive GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are two of the most common acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.

Contact Information

Headquarters
100 Campus Drive, Suite 102FLORHAM PARK, NJ, United States 07932
Phone
302-636-5400
Fax
302-636-5454

Executives

Independent Chairman of the Board
Michael Cola
President, Chief Executive Officer, Director
Terrie Curran
Co-Founder, Chief Operating Officer
Azmi Nabulsi
Co-Founder, Director
David Socks
Chief Financial Officer and Business Officer
Molly Henderson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$598.2M
Revenue (TTM)
$2.6M
Shares Outstanding
58.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.68
EPS
$-4.41
Book Value
$-1.26
P/E Ratio
-2.3x
Price/Sales (TTM)
230.6
Price/Cash Flow (TTM)
---
Operating Margin
-7,987.24%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.